NNVC Stock Summary and Trading Ideas (Nanoviricides | AMEX:NNVC)

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Nanoviricides trades on the AMEX stock market under the symbol NNVC.

As of June 5, 2026, NNVC stock price declined to $1.38 with 640,528 million shares trading.

NNVC has a beta of 1.85, meaning it tends to be more sensitive to market movements. NNVC has a correlation of 0.09 to the broad based SPY ETF.

NNVC has a market cap of $31.44 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NNVC traded as high as $3.59 and as low as $.85.

The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF.

NNVC has underperformed the market in the last year with a price return of -7.4% while the SPY ETF gained +25.6%. However, in the short term, NNVC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +49.0% vs +8.5% return in SPY. But in the last 2 weeks, NNVC shares have been beat by the market, returning -15.9% compared to an SPY return of -1.1%.

NNVC support price is $1.39 and resistance is $1.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.